Latest African Malaria Network Trust Stories
Long-term follow-up of a phase II study from KEMRI-Wellcome Trust Research Programme and Oxford University researchers in Kenya shows that the efficacy of a malaria vaccine candidate, RTS,S, wanes over time and varies with exposure to the malaria parasite.
According to research from Penn State University, malaria parasites evolving in vaccinated laboratory mice become more lethal.
Giving young children medicine once a month during the rainy season to protect them against malaria could prevent tens of thousands of deaths each year in some areas of Africa.
A new probe into the perils of malaria has found that 1.2 million people die each year from the disease, 50 percent more than previously thought, and 42 percent of those numbers occur in older children and adults.
A new candidate malaria vaccine with the potential to neutralize all strains of the most deadly species of malaria parasite has been developed by a team led by scientists at the University of Oxford.
- A serpent whose bite was fabled to produce intense thirst.